Choi v. Mario Badescu Skin Care, Inc.

In December 2012, the Korean Ministry of Food and Drug Safety suspended the sales of Mario Badescu's Healing Cream after testing revealed the product contained two unlabeled corticosteroids, hydrocortisone and triamcinolone acetonide. Plaintiffs, on behalf of themselves and a nationwide class of face cream purchasers, filed suit seeking economic damages and equitable relief. Defendants agreed to settle the action before the class was certified. In this appeal, nine class members raise numerous challenges. In the published portion of the opinion, the court held that the one-time publication of the notice of settlement did not violate the Consumers Legal Remedies Act, Civ. Code, 1750 et seq. The court affirmed the judgment. View "Choi v. Mario Badescu Skin Care, Inc." on Justia Law